Australia’s efforts to import more than 3 million doses of AstraZeneca vaccines continue to be hampered, despite a third of the jabs being assigned to COVID-19 ravaged Papua New Guinea.
As the first Australian-made vaccine doses left the factory on Wednesday, Health Department officials said various attempts had been made to extract the vaccine doses contracted to Australia from the EU, but to no avail.
Loading...
Ronald Mizen is the Financial Review’s political correspondent, reporting from the press gallery at Parliament House, Canberra. Connect with Ronald on Twitter. Email Ronald at ronald.mizen@afr.com
Tom McIlroy is the Financial Review’s Canberra bureau chief based in the press gallery at Parliament House. He was previously the AFR’s political correspondent. Connect with Tom on Twitter. Email Tom at thomas.mcilroy@afr.com
